Amarin Corporation: Commercializing Vascepa, the first and only pure EPA omega-3 fatty acid approved to lower triglyceride levels in adults. Presented (+) data from REDUCE-IT CV Outcomes trial at AHA. 2019 guidance of $380-420M, or 66-83% higher y/y.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
USA
Clinical Stage
Marketed
Disease Space
Cardiovascular
Finance
Revenues
Industry
Biotechnology, Pharmaceuticals
Listing
Public, USA
Market Cap
1B +
Therapeutic Modalities
Small Molecule
Website:
Profiles:
Address:
1430 Route 206
Suite 200
Bedminster, NJ 07921
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Solebury Trout Management Access: SF 2020

San Francisco, CA, United States, January 13 – January 16, 2020

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2019 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.